Neuronal pathways linking substance P to drug addiction and stress

Brain Research

Volumn 1314, Issue , 2010, Pages 175-182

  Commons, K G ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Neurokinin 1; Nucleus accumbens; Serotonin; Stress; Substance P

Indexed keywords

COCAINE; NEUROKININ; NEUROKININ 1 RECEPTOR; SUBSTANCE P;

ANTINOCICEPTION; ARTICLE; BEHAVIOR; CHOLINERGIC NERVE CELL; DRUG DEPENDENCE; DRUG SENSITIZATION; DRUG TOLERANCE; FOREBRAIN; GLOBUS PALLIDUS; HUMAN; MOTIVATION; NEUROTRANSMISSION; NONHUMAN; NORADRENERGIC SYSTEM; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RELAPSE; REWARD; SEROTONINERGIC SYSTEM; STRESS;

ANALGESICS, OPIOID; ANIMALS; BRAIN; COMORBIDITY; HUMANS; NEURAL PATHWAYS; NUCLEUS ACCUMBENS; OPIOID-RELATED DISORDERS; RAPHE NUCLEI; STRESS, PSYCHOLOGICAL; SUBSTANCE P; SUBSTANCE-RELATED DISORDERS;

ANIMALIA;

EID: 75149134194     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.11.014     Document Type: Article

References (99)

1. 1b-adrenergic receptors entirely mediate dopamine release, locomotor response and behavioural sensitization to opiates and psychostimulants. Eur. J. Neurosci. 20 (2004) 3073-3084
2. Bain G.T., and Kornetsky C. Naloxone attenuation of the effect of cocaine on rewarding brain stimulation. Life Sci. 40 (1987) 1119-1125
3. Bell M.I., Richardson P.J., and Lee K. Characterization of the mechanism of action of tachykinins in rat striatal cholinergic interneurons. Neuroscience 87 (1998) 649-658
4. Berlanga M.L., Olsen C.M., Chen V., Ikegami A., Herring B.E., Duvauchelle C.L., and Alcantara A.A. Cholinergic interneurons of the nucleus accumbens and dorsal striatum are activated by the self-administration of cocaine. Neuroscience 120 (2003) 1149-1156
5. Berridge K.C. Motivation concepts in behavioral neuroscience. Physiol. Behav. 81 (2004) 179-209
6. Bilsky E.J., Montegut M.J., Delong C.L., and Reid L.D. Opioidergic modulation of cocaine conditioned place preferences. Life Sci. 50 (1992) PL85-PL90
7. Bland S.T., Hargrave D., Pepin J.L., Amat J., Watkins L.R., and Maier S.F. Stressor controllability modulates stress-induced dopamine and serotonin efflux and morphine-induced serotonin efflux in the medial prefrontal cortex. Neuropsychopharmacology 28 (2003) 1589-1596
8. Cador M., Rivet J.M., Kelley A.E., Le Moal M., and Stinus L. Substance P, neurotensin and enkephalin injections into the ventral tegmental area: comparative study on dopamine turnover in several forebrain structures. Brain Res. 486 (1989) 357-363
9. Carlezon Jr. W.A., and Thomas M.J. Biological substrates of reward and aversion: a nucleus accumbens activity hypothesis. Neuropharmacology 56 Suppl. 1 (2009) 122-132
10. Chen L.W., Wei L.C., Liu H.L., and Rao Z.R. Noradrenergic neurons expressing substance P receptor (NK1) in the locus coeruleus complex: a double immunofluorescence study in the rat. Brain Res. 873 (2000) 155-159
11. Commons, K.G., 2009. Locally collateralizing glutamate neurons in the dorsal raphe nucleus responsive to substance P contain vesicular glutamate transporter 3 (VGLUT3). J. Chem. Neuroanat. 38 (4), 273-281.
12. Commons, K.G., Valentino, R.J., 2002. Cellular basis for the effects of substance P in the periaqueductal gray and dorsal raphe nucleus. J. Comp. Neurol. 447 (1), 82-97.
13. Commons, K.G., Serock, M.R., 2009. Coincidence of neurokinin 1 receptor with the vesicular glutamate transporter 3 (VGLUT3) in the rat forebrain. Neurosci. Lett. 464 (3), 188-192.
14. Corrigall W.A., and Coen K.M. Opiate antagonists reduce cocaine but not nicotine self-administration. Psychopharmacology (Berl) 104 (1991) 167-170
15. Culman J., and Unger T. Central tachykinins: mediators of defence reaction and stress reactions. Can. J. Physiol. Pharmacol. 73 (1995) 885-891
16. Culman J., and Unger T. Central tachykinins: mediators of defence reaction and stress reactions. Can. J. Physiol. Pharmacol. 73 (1995) 885-891
17. Culman J., Klee S., Ohlendorf C., and Unger T. Effect of tachykinin receptor inhibition in the brain on cardiovascular and behavioral responses to stress. J. Pharmacol. Exp. Ther. 280 (1997) 238-246
18. Cunningham K.A., Paris J.M., and Goeders N.E. Serotonin neurotransmission in cocaine sensitization. Ann. N. Y. Acad. Sci. 654 (1992) 117-127
19. De Felipe C., Herrero J.F., O'Brien J.A., Palmer J.A., Doyle C.A., Smith A.J., Laird J.M., Belmonte C., Cervero F., and Hunt S.P. Altered nociception, analgesia and aggression in mice lacking the receptor for substance P [see comments]. Nature 392 (1998) 394-397
20. De Felipe C., Herrero J.F., O'Brien J.A., Palmer J.A., Doyle C.A., Smith A.J., Laird J.M., Belmonte C., Cervero F., and Hunt S.P. Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature 392 (1998) 394-397
21. De Vries T.J., and Shippenberg T.S. Neural systems underlying opiate addiction. J. Neurosci. 22 (2002) 3321-3325
22. Ebner K., Rupniak N.M., Saria A., and Singewald N. Substance P in the medial amygdala: emotional stress-sensitive release and modulation of anxiety-related behavior in rats. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 4280-4285
23. Ebner K., Muigg P., Singewald G., and Singewald N. Substance P in stress and anxiety: NK-1 receptor antagonism interacts with key brain areas of the stress circuitry. Ann. N. Y. Acad. Sci. 1144 (2008) 61-73
24. Ebner K., Singewald G.M., Whittle N., Ferraguti F., and Singewald N. Neurokinin 1 receptor antagonism promotes active stress coping via enhanced septal 5-HT transmission. Neuropsychopharmacology 33 (2008) 1929-1941
25. Elliott P.J., and Iversen S.D. Behavioural effects of tachykinins and related peptides. Brain Res. 381 (1986) 68-76
26. Elliott P.J., Alpert J.E., Bannon M.J., and Iversen S.D. Selective activation of mesolimbic and mesocortical dopamine metabolism in rat brain by infusion of a stable substance P analogue into the ventral tegmental area. Brain Res. 363 (1986) 145-147
27. Fibiger H., Cardinal R., Parkinson J., and Robbins T. Reward, motivation, cognition: psychobiology of mesotenencelphalic systems. In: Bloom F. (Ed). Handbook of Physiology-The Nervous System Vol. 4 (1986), American Physiological Society, Bethesda, MD 647-675
28. Fremeau Jr. R.T., Burman J., Qureshi T., Tran C.H., Proctor J., Johnson J., Zhang H., Sulzer D., Copenhagen D.R., Storm-Mathisen J., Reimer R.J., Chaudhry F.A., and Edwards R.H. The identification of vesicular glutamate transporter 3 suggests novel modes of signaling by glutamate. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 14488-14493
29. Gadd C.A., Murtra P., De Felipe C., and Hunt S.P. Neurokinin-1 receptor-expressing neurons in the amygdala modulate morphine reward and anxiety behaviors in the mouse. J. Neurosci. 23 (2003) 8271-8280
30. Galarraga E., Hernandez-Lopez S., Reyes A., Miranda I., Bermudez-Rattoni F., Vilchis C., and Bargas J. Cholinergic modulation of neostriatal output: a functional antagonism between different types of muscarinic receptors. J. Neurosci. 19 (1999) 3629-3638
31. Goodman A. Neurobiology of addiction. An integrative review. Biochem. Pharmacol. 75 (2008) 266-322
32. Gras C., Herzog E., Bellenchi G.C., Bernard V., Ravassard P., Pohl M., Gasnier B., Giros B., and El Mestikawy S. A third vesicular glutamate transporter expressed by cholinergic and serotoninergic neurons. J. Neurosci. 22 (2002) 5442-5451
33. Graybiel A.M., Aosaki T., Flaherty A.W., and Kimura M. The basal ganglia and adaptive motor control. Science 265 (1994) 1826-1831
34. Groenewegen H.J., and Russchen F.T. Organization of the efferent projections of the nucleus accumbens to pallidal, hypothalamic, and mesencephalic structures: a tracing and immunohistochemical study in the cat. J. Comp. Neurol. 223 (1984) 347-367
35. Guiard B.P., Guilloux J.P., Reperant C., Hunt S.P., Toth M., and Gardier A.M. Substance P neurokinin 1 receptor activation within the dorsal raphe nucleus controls serotonin release in the mouse frontal cortex. Mol. Pharmacol. 72 (2007) 1411-1418
36. Haddjeri N., and Blier P. Neurokinin-1 receptor antagonists modulate brain noradrenaline and serotonin interactions. Eur. J. Pharmacol. 600 (2008) 64-70
37. Hasenohrl R.U., Gerhardt P., and Huston J.P. Positively reinforcing effects of the neurokinin substance P in the basal forebrain: mediation by its C-terminal sequence. Exp. Neurol. 115 (1992) 282-291
38. Hasenohrl R.U., Frisch C., and Huston J.P. Evidence for anatomical specificity for the reinforcing effects of SP in the nucleus basalis magnocellularis. NeuroReport 9 (1998) 7-10
39. Hasenohrl R.U., Jentjens O., De Souza Silva M.A., Tomaz C., and Huston J.P. Anxiolytic-like action of neurokinin substance P administered systemically or into the nucleus basalis magnocellularis region. Eur. J. Pharmacol. 354 (1998) 123-133
40. Heimer L., and Alheid G.F. Piecing together the puzzle of basal forebrain anatomy. Adv. Exp. Med. Biol. 295 (1991) 1-42
41. Hill R. NK1 (substance P) receptor antagonists-why are they not analgesic in humans?. Trends Pharmacol. Sci. 21 (2000) 244-246
42. Hnasko T.S., Sotak B.N., and Palmiter R.D. Morphine reward in dopamine-deficient mice. Nature 438 (2005) 854-857
43. Hokfelt T., Pernow B., and Wahren J. Substance P: a pioneer amongst neuropeptides. J. Intern. Med. 249 (2001) 27-40
44. Jabourian M., Venance L., Bourgoin S., Ozon S., Perez S., Godeheu G., Glowinski J., and Kemel M.L. Functional mu opioid receptors are expressed in cholinergic interneurons of the rat dorsal striatum: territorial specificity and diurnal variation. Eur. J. Neurosci. 21 (2005) 3301-3309
45. Jasmin L., Narasaiah M., and Tien D. Noradrenaline is necessary for the hedonic properties of addictive drugs. Vascul. Pharmacol. 45 (2006) 243-250
46. Kaneko T., Shigemoto R., Nakanishi S., and Mizuno N. Substance P receptor-immunoreactive neurons in the rat neostriatum are segregated into somatostatinergic and cholinergic aspiny neurons. Brain Res. 631 (1993) 297-303
47. Kirby L.G., Chou-Green J.M., Davis K., and Lucki I. The effects of different stressors on extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid. Brain Res. 760 (1997) 218-230
48. Kombian S.B., Ananthalakshmi K.V., Zidichouski J.A., and Saleh T.M. Substance P and cocaine employ convergent mechanisms to depress excitatory synaptic transmission in the rat nucleus accumbens in vitro. Eur. J. Neurosci. 29 (2009) 1579-1587
49. Koob G.F. The role of the striatopallidal and extended amygdala systems in drug addiction. Ann. N. Y. Acad. Sci. 877 (1999) 445-460
50. Koob G.F. Dynamics of neuronal circuits in addiction: reward, antireward, and emotional memory. Pharmacopsychiatry 42 Suppl. 1 (2009) S32-S41
51. Korotkova T.M., Brown R.E., Sergeeva O.A., Ponomarenko A.A., and Haas H.L. Effects of arousal- and feeding-related neuropeptides on dopaminergic and GABAergic neurons in the ventral tegmental area of the rat. Eur. J. Neurosci. 23 (2006) 2677-2685
52. Lanteri C., Salomon L., Torrens Y., Glowinski J., and Tassin J.P. Drugs of abuse specifically sensitize noradrenergic and serotonergic neurons via a non-dopaminergic mechanism. Neuropsychopharmacology 33 (2008) 1724-1734
53. Lee T., Kaneko T., Shigemoto R., Nomura S., and Mizuno N. Collateral projections from striatonigral neurons to substance P receptor-expressing intrinsic neurons in the striatum of the rat. J. Comp. Neurol. 388 (1997) 250-264
54. Liu R., Ding Y., and Aghajanian G.K. Neurokinins activate local glutamatergic inputs to serotonergic neurons of the dorsal raphe nucleus. Neuropsychopharmacology 27 (2002) 329-340
55. 2 receptor, substance P and enkephalin messenger RNAs in the neurons projecting from the nucleus accumbens. Neuroscience 82 (1998) 767-780
56. Marksteiner J., Saria A., and Krause J.E. Comparative distribution of neurokinin B-, substance P- and enkephalin-like immunoreactivities and neurokinin B messenger RNA in the basal forebrain of the rat: evidence for neurochemical compartmentation. Neuroscience 51 (1992) 107-120
57. Martin G., Nie Z., and Siggins G.R. mu-Opioid receptors modulate NMDA receptor-mediated responses in nucleus accumbens neurons. J. Neurosci. 17 (1997) 11-22
58. Martone M.E., Armstrong D.M., Young S.J., and Groves P.M. Ultrastructural examination of enkephalin and substance P input to cholinergic neurons within the rat neostriatum. Brain Res. 594 (1992) 253-262
59. McBride W.J., Murphy J.M., and Ikemoto S. Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies. Behav. Brain Res. 101 (1999) 129-152
60. McGaugh J.L. The amygdala modulates the consolidation of memories of emotionally arousing experiences. Annu. Rev. Neurosci. 27 (2004) 1-28
61. Murtra P., Sheasby A.M., Hunt S.P., and De Felipe C. Rewarding effects of opiates are absent in mice lacking the receptor for substance P. Nature 405 (2000) 180-183
62. Nakaya Y., Kaneko T., Shigemoto R., Nakanishi S., and Mizuno N. Immunohistochemical localization of substance P receptor in the central nervous system of the adult rat. J. Comp. Neurol. 347 (1994) 249-274
63. Napier T.C., Mitrovic I., Churchill L., Klitenick M.A., Lu X.Y., and Kalivas P.W. Substance P in the ventral pallidum: projection from the ventral striatum, and electrophysiological and behavioral consequences of pallidal substance P. Neuroscience 69 (1995) 59-70
64. Nickerson Poulin A., Guerci A., El Mestikawy S., and Semba K. Vesicular glutamate transporter 3 immunoreactivity is present in cholinergic basal forebrain neurons projecting to the basolateral amygdala in rat. J. Comp. Neurol. 498 (2006) 690-711
65. Nicoll R.A., Schenker C., and Leeman S.E. Substance P as a transmitter candidate. Annu. Rev. Neurosci. 3 (1980) 227-268
66. Nikolaus S., Huston J.P., and Hasenohrl R.U. Reinforcing effects of neurokinin substance P in the ventral pallidum: mediation by the tachykinin NK1 receptor. Eur. J. Pharmacol. 370 (1999) 93-99
67. 2 receptor agonists on the behavioral and neurochemical consequences of repeated nicotine treatment. Eur. J. Pharmacol. 420 (2001) 45-54
68. Panagis G., Spyraki C., and Miliaressis E. Poststimulation excitability of ventral pallidum self-stimulation neurons. Behav. Neurosci. 109 (1995) 777-781
69. Parent A., Cicchetti F., and Beach T.G. Striatal neurones displaying substance P (NK1) receptor immunoreactivity in human and non-human primates. NeuroReport 6 (1995) 721-724
70. Pfeiffer M., Kirscht S., Stumm R., Koch T., Wu D., Laugsch M., Schroder H., Hollt V., and Schulz S. Heterodimerization of substance P and mu-opioid receptors regulates receptor trafficking and resensitization. J. Biol. Chem. 278 (2003) 51630-51637
71. Pickel V.M., Joh T.H., and Reis D.J. Monoamine-synthesizing enzymes in central dopaminergic, noradrenergic and serotonergic neurons. Immunocytochemical localization by light and electron microscopy. J. Histochem. Cytochem. 24 (1976) 306-792
72. Pickel V.M., Douglas J., Chan J., Gamp P.D., and Bunnett N.W. Neurokinin 1 receptor distribution in cholinergic neurons and targets of substance P terminals in the rat nucleus accumbens. J. Comp. Neurol. 423 (2000) 500-511
73. Placenza F.M., Fletcher P.J., Rotzinger S., and Vaccarino F.J. Infusion of the substance P analogue, DiMe-C7, into the ventral tegmental area induces reinstatement of cocaine-seeking behaviour in rats. Psychopharmacology (Berl) 177 (2004) 111-120
74. 2 receptors. Behav. Pharmacol. 14 (2003) 207-213
75. Regoli D., Boudon A., and Fauchere J.L. Receptors and antagonists for substance P and related peptides. Pharmacol. Rev. 46 (1994) 551-599
76. Ripley T.L., Gadd C.A., De Felipe C., Hunt S.P., and Stephens D.N. Lack of self-administration and behavioural sensitisation to morphine, but not cocaine, in mice lacking NK1 receptors. Neuropharmacology 43 (2002) 1258-1268
77. Rosen A., Zhang Y.X., Lund I., Lundeberg T., and Yu L.C. Substance P microinjected into the periaqueductal gray matter induces antinociception and is released following morphine administration. Brain Res. 1001 (2004) 87-94
78. Salomon L., Lanteri C., Glowinski J., and Tassin J.P. Behavioral sensitization to amphetamine results from an uncoupling between noradrenergic and serotonergic neurons. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 7476-7481
79. Santarelli L., Gobbi G., Debs P.C., Sibille E.T., Blier P., Hen R., and Heath M.J. Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 1912-1917
80. Schafer M.K., Varoqui H., Defamie N., Weihe E., and Erickson J.D. Molecular cloning and functional identification of mouse vesicular glutamate transporter 3 and its expression in subsets of novel excitatory neurons. J. Biol. Chem. 277 (2002) 50734-50748
81. Schroeder J.A., Hummel M., Simpson A.D., Sheikh R., Soderman A.R., and Unterwald E.M. A role for mu opioid receptors in cocaine-induced activity, sensitization, and reward in the rat. Psychopharmacology (Berl) 195 (2007) 265-272
82. Shippenberg T.S., and Elmer G.I. The neurobiology of opiate reinforcement. Crit. Rev. Neurobiol. 12 (1998) 267-303
83. Sills T.L., and Fletcher P.J. Fluoxetine attenuates morphine-induced locomotion and blocks morphine-sensitization. Eur. J. Pharmacol. 337 (1997) 161-164
84. Smith D.W., Hewson L., Fuller P., Williams A.R., Wheeldon A., and Rupniak N.M. The substance P antagonist L-760,735 inhibits stress-induced NK(1) receptor internalisation in the basolateral amygdala. Brain Res. 848 (1999) 90-95
85. Smith K.S., Tindell A.J., Aldridge J.W., and Berridge K.C. Ventral pallidum roles in reward and motivation. Behav. Brain Res. 196 (2009) 155-167
86. Solomon R.L., and Corbit J.D. An opponent-process theory of motivation: I. Temporal dynamics of affect. Psychol. Rev. 81 (1974) 119-145
87. Spanagel R., and Weiss F. The dopamine hypothesis of reward: past and current status. Trends Neurosci. 22 (1999) 521-527
88. Spitznagel H., Baulmann J., Blume A., Unger T., and Culman J. C-FOS expression in the rat brain in response to substance P and neurokinin B. Brain Res. 916 (2001) 11-21
89. Svingos A.L., Colago E.E., and Pickel V.M. Vesicular acetylcholine transporter in the rat nucleus accumbens shell: subcellular distribution and association with mu-opioid receptors. Synapse 40 (2001) 184-192
90. Takayama H., Ota Z., and Ogawa N. Effect of immobilization stress on neuropeptides and their receptors in rat central nervous system. Regulatory Pept. 15 (1986) 239-248
91. Unger T., Carolus S., Demmert G., Ganten D., Lang R.E., Maser-Gluth C., Steinberg H., and Veelken R. Substance P induces a cardiovascular defense reaction in the rat: pharmacological characterization. Circ. Res. 63 (1988) 812-820
92. Valentino R.J., Foote S.L., and Page M.E. The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responses. Ann. N. Y. Acad. Sci. 697 (1993) 173-188
93. Valentino R.J., Bey V., Pernar L., and Commons K.G. Substance P acts through local circuits within the rat dorsal raphe nucleus to alter serotonergic neuronal activity. J. Neurosci. 23 (2003) 7155-7159
94. + channel in rat brain neurons. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 1590-1594
95. Von Euler U., and Gaddum J. An unidentified depressor substance in certain tissue extracts. J. Physiol. 72 (1931) 74-87
96. Will M.J., Der-Avakian A., Bland S.T., Grahn R.E., Hammack S.E., Sparks P.D., Pepin J.L., Watkins L.R., and Maier S.F. Electrolytic lesions and pharmacological inhibition of the dorsal raphe nucleus prevent stressor potentiation of morphine conditioned place preference in rats. Psychopharmacology (Berl) 171 (2004) 191-198
97. Yan Q.S., and Yan S.E. Activation of 5-HT(1B/1D) receptors in the mesolimbic dopamine system increases dopamine release from the nucleus accumbens: a microdialysis study. Eur. J. Pharmacol. 418 (2001) 55-64
98. Yu Y.J., Arttamangkul S., Evans C.J., Williams J.T., and von Zastrow M. Neurokinin 1 receptors regulate morphine-induced endocytosis and desensitization of mu-opioid receptors in CNS neurons. J. Neurosci. 29 (2009) 222-233
99. Zaborszky L., and Cullinan W.E. Projections from the nucleus accumbens to cholinergic neurons of the ventral pallidum: a correlated light and electron microscopic double-immunolabeling study in rat. Brain Res. 570 (1992) 92-101